Hsbc Holdings PLC Raises Stake in Astera Labs, Inc. $ALAB

Hsbc Holdings PLC raised its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 162.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 26,874 shares of the company’s stock after acquiring an additional 16,626 shares during the period. Hsbc Holdings PLC’s holdings in Astera Labs were worth $2,437,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Straight Path Wealth Management grew its holdings in shares of Astera Labs by 1.5% during the 2nd quarter. Straight Path Wealth Management now owns 6,850 shares of the company’s stock valued at $619,000 after purchasing an additional 100 shares during the last quarter. First Horizon Advisors Inc. increased its holdings in shares of Astera Labs by 12.4% in the second quarter. First Horizon Advisors Inc. now owns 982 shares of the company’s stock worth $89,000 after buying an additional 108 shares during the period. Advisors Asset Management Inc. lifted its stake in shares of Astera Labs by 68.6% in the 2nd quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock valued at $43,000 after acquiring an additional 194 shares during the last quarter. Wealthcare Advisory Partners LLC boosted its holdings in Astera Labs by 0.8% during the 2nd quarter. Wealthcare Advisory Partners LLC now owns 29,160 shares of the company’s stock valued at $2,637,000 after acquiring an additional 221 shares during the period. Finally, Main Management ETF Advisors LLC grew its position in Astera Labs by 1.7% during the 2nd quarter. Main Management ETF Advisors LLC now owns 14,660 shares of the company’s stock worth $1,326,000 after acquiring an additional 240 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, CEO Jitendra Mohan sold 90,459 shares of Astera Labs stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the sale, the chief executive officer directly owned 2,080,418 shares in the company, valued at $301,015,680.42. The trade was a 4.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, General Counsel Philip Mazzara sold 10,000 shares of the stock in a transaction on Wednesday, October 1st. The stock was sold at an average price of $192.16, for a total value of $1,921,600.00. Following the completion of the transaction, the general counsel owned 151,573 shares of the company’s stock, valued at approximately $29,126,267.68. This trade represents a 6.19% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 586,936 shares of company stock worth $89,331,140 over the last quarter. Company insiders own 12.50% of the company’s stock.

Analysts Set New Price Targets

Several analysts have weighed in on ALAB shares. Deutsche Bank Aktiengesellschaft boosted their price objective on Astera Labs from $160.00 to $200.00 and gave the company a “buy” rating in a research report on Tuesday, September 2nd. Morgan Stanley reiterated an “overweight” rating and set a $210.00 price target on shares of Astera Labs in a report on Wednesday. Northland Securities set a $175.00 price target on shares of Astera Labs in a report on Monday, November 17th. BNP Paribas Exane started coverage on shares of Astera Labs in a research note on Thursday, November 20th. They set an “outperform” rating and a $225.00 price objective for the company. Finally, Citigroup raised their target price on Astera Labs from $160.00 to $275.00 and gave the stock a “buy” rating in a research note on Wednesday, September 17th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $187.06.

Astera Labs Trading Up 5.7%

Shares of ALAB opened at $161.23 on Friday. Astera Labs, Inc. has a 1-year low of $47.13 and a 1-year high of $262.90. The firm’s 50-day moving average price is $170.02 and its 200-day moving average price is $151.11. The firm has a market capitalization of $27.23 billion, a price-to-earnings ratio of 145.25, a PEG ratio of 3.00 and a beta of 1.51.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.39 by $0.10. The business had revenue of $230.58 million during the quarter, compared to analyst estimates of $206.42 million. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. Astera Labs’s quarterly revenue was up 103.9% compared to the same quarter last year. During the same period last year, the business posted $0.23 earnings per share. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, research analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.